Adicet Bio Inc (ACET)

Mar 25, 2025

The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative - GlobeNewswire Inc.

Mar 25, 2025

Mar 24, 2025

Adicet Bio (NASDAQ:ACET) Earns “Buy” Rating from Guggenheim - Armenian Reporter

Mar 24, 2025

Mar 23, 2025

Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey

Mar 23, 2025

Mar 23, 2025

Guggenheim Reiterates Buy Rating for Adicet Bio (NASDAQ:ACET) - Defense World

Mar 23, 2025

Mar 22, 2025

10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey

Mar 22, 2025

Mar 18, 2025

Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9% - Defense World

Mar 18, 2025

Mar 17, 2025

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 17, 2025

Mar 12, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com Canada

Mar 12, 2025

Mar 12, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Adicet Bio (ACET) Expected to Announce Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 10, 2025

Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio - TipRanks

Mar 10, 2025

Mar 09, 2025

Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World

Mar 09, 2025

Mar 07, 2025

Adicet Bio Advances Clinical Trials and Financial Stability - TipRanks

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Neutral on Adicet Bio stock By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Neutral on Adicet Bio stock - Investing.com India

Mar 07, 2025

Mar 07, 2025

Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes - TipRanks

Mar 07, 2025

Mar 07, 2025

Adicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data - TipRanks

Mar 07, 2025

Mar 06, 2025

Adicet Bio Inc Files For Mixed Shelf Of Up To $250 Million -March 06, 2025 at 04:59 pm EST - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Lelezard

Mar 06, 2025

Mar 06, 2025

Adicet Bio, Inc Q4 Loss Decreases - Nasdaq

Mar 06, 2025

Mar 06, 2025

Adicet Bio reports Q4 EPS (32c), consensus (35c) - TipRanks

Mar 06, 2025

Mar 06, 2025

Can Adicet Bio's $176M War Chest and Fast Track Status Transform Autoimmune Treatment? - StockTitan

Mar 06, 2025

Mar 06, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Average Target Price from Analysts - Defense World

Mar 06, 2025

Mar 05, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World

Mar 05, 2025

Mar 04, 2025

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting - BioSpace

Mar 04, 2025

Feb 28, 2025

Adicet Bio's (ACET) "Neutral" Rating Reaffirmed at HC Wainwright - MarketBeat

Feb 28, 2025

Feb 27, 2025

Adicet Bio shares rise on FDA Fast Track Designation for ADI-001 - Investing.com

Feb 27, 2025

Feb 27, 2025

FDA fast tracks Adicet Bio's autoimmune therapy By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

FDA fast tracks Adicet Bio’s autoimmune therapy - Investing.com

Feb 27, 2025

Feb 27, 2025

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc) - Lelezard

Feb 27, 2025

Feb 27, 2025

FDA fast tracks Adicet Bio’s autoimmune therapy By Investing.com - Investing.com UK

Feb 27, 2025

Feb 27, 2025

Adicet's Systemic Sclerosis Therapy Earns Critical FDA Fast Track StatusWhat This Means for Patients - StockTitan

Feb 27, 2025

Feb 19, 2025

Adicet Bio (NASDAQ:ACET) versus Corvus Pharmaceuticals (NASDAQ:CRVS) Head to Head Analysis - Defense World

Feb 19, 2025

Feb 17, 2025

Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa

Feb 17, 2025

Feb 17, 2025

Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com

Feb 17, 2025

Feb 13, 2025

Healthy Upside Potential: Adicet Bio Inc (ACET) - SETE News

Feb 13, 2025

Feb 10, 2025

Adicet Bio Inc [ACET] Insider Activity: An Update for Investors - Knox Daily

Feb 10, 2025

Feb 10, 2025

Investor Alert: What’s Really Going On At Adicet Bio Inc (NASDAQ: ACET) - Stocks Register

Feb 10, 2025

Feb 10, 2025

Adicet Bio (NASDAQ:ACET) Earns Market Perform Rating from JMP Securities - MarketBeat

Feb 10, 2025

Feb 09, 2025

Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.50 - MarketBeat

Feb 09, 2025

Feb 09, 2025

Adicet Bio reports progress in clinical trial enrollments - MSN

Feb 09, 2025

Feb 09, 2025

HC Wainwright Reaffirms Neutral Rating for Adicet Bio (NASDAQ:ACET) - MarketBeat

Feb 09, 2025

Feb 08, 2025

Adicet Bio (NASDAQ:ACET) Earns “Market Perform” Rating from JMP Securities - Defense World

Feb 08, 2025

Feb 07, 2025

Top investors say Adicet Bio Inc (ACET) ticks everything they need - SETE News

Feb 07, 2025

Feb 07, 2025

Major Win – FDA Grants Fast Track Designation to Adicet Bio’s ADI-001 for Lupus Disease - geneonline

Feb 07, 2025

Feb 06, 2025

Adicet Bio Inc [NASDAQ: ACET] Sees Increase in Stock Value - Knox Daily

Feb 06, 2025